35th week of 2008 patent applcation highlights part 46 |
Patent application number | Title | Published |
20080206316 | Chromium-Fatty Acid Compounds and Methods of Making and Using Thereof - Disclosed are compounds comprising one or more chromium atoms bonded to one or more fatty acids. Also disclosed are nutritional supplements, pharmaceutical formulations, delivery devices, and foodstuffs comprising the disclosed compounds. Methods of using the disclosed compounds and compositions to improve health are also disclosed. | 2008-08-28 |
20080206317 | Ternary Non-Lamellar Lipid Compositions - The present invention provides a particulate composition including; a) at least 50 % of at least one structure forming amphiphile, b) 0 to 40% of at least one structure swelling amphiphile, and c) 2 to 20% of at least one dispersion stabilising polymeric amphiphile, where all parts are by weight relative to the sum of the weights of a+b+c and wherein the composition comprises non-lamellar particles or forms non-lamellar particles when contacted with an aqueous fluid. Where component b) is 0% then component a) comprises at least two structure forming amphiphiles. The invention also provides pharmaceutical compositions of the compositions and kits containing the compositions for establishing a pharmaceutical formulation of an active agent. | 2008-08-28 |
20080206318 | Therapeutic compositions that alter the immune response - The invention is therapeutic methods and compositions that alter the immunogenicity of the host. | 2008-08-28 |
20080206319 | Hexosylceramides as Adjuvants and Their Uses in Pharmaceutical Compositions - The present invention relates to new adjuvants and the uses in pharmaceutical compositions, like in vaccines. In particular, the present invention provides new compounds useful as adjuvants for prophylactic and/or therapeutic vaccination in the treatment of infectious diseases, inflammatory diseases, autoimmune diseases, tumours, allergies as well as for the control of fertility in human or animal populations. The compounds are particularly useful not only as systemic, but preferably as mucosal adjuvants. In addition, the invention relates to its uses as active ingredients in pharmaceutical compositions. | 2008-08-28 |
20080206320 | COMPOSITION COMPRISING AT LEAST ONE 15-PGDH INHIBITOR - The invention relates to a cosmetic composition containing at least one 15-hydroxy-prostaglandin dehydrogenase inhibitor and cosmetically acceptable excipients. It also relates to a method of cosmetic treatment for promoting the growth and/or preventing or delaying the loss of hair, and the use of a 15-hydroxyprostaglandin dehydrogenase inhibitor for the preparation of a composition intended for controlling hair loss and/or for promoting hair regrowth. | 2008-08-28 |
20080206321 | Oral drug delivery system - Dosage forms and drug delivery devices suitable for administration of pharmaceutical compounds and compositions, including the oral drug administration of compounds. | 2008-08-28 |
20080206322 | Pharmaceutical Multiparticulate Composit Ion Comprising Mycophenolic Acid or Myco Phenolate Sodium and Combination Compositions with Rapamycin - The present invention relates to a novel composition, e.g. of mycophenolic acid, a salt or a prodrug thereof, in a modified release form. | 2008-08-28 |
20080206323 | Soft Gelatin Capsules - The present invention relates to soft gelatin capsules characterized in that the shell includes a cyclodextrin and in that the filling material contains a liposoluble drug capable of forming a complex with said cyclodextrin for improving the solubility of the active ingredient upon disintegration of the soft gelatin capsule. | 2008-08-28 |
20080206324 | PELLETS HAVING AN ACTIVE COMPOUND MATRIX AND A POLYMER COATING, AND A PROCESS FOR THE PRODUCTION OF THE PELLETS - An active compound-containing pellet has a polymer coating of an anionic (meth)acrylate copolymer and a pharmaceutically active substance, embedded in a polymer matrix of one or more polymers, a particle size in the range from 300 to 1100 μm, a friability of at most 0.1%, measured using 200 g of pellets in a screening machine having a 200 μm screen, a screening diameter of 20 cm and 1.5 mm shaking amplitude at a shaking frequency of 50 l/sec for 10 min in the presence of six rubber cubes having a 1.8 cm edge length, with the proviso that the pellet releases no more than 10% of the active compound in a release test according to USP in artificial gastric juice at pH 1.2 after 120 min. | 2008-08-28 |
20080206325 | Encapsulated Active Ingredients, Methods of Preparation and Their Use - The present invention relates to particles that include an active ingredient that is encapsulated first by coacervation, and then by a glassy matrix. The glassy matrix includes 3-50 wt % of a hydrophobically modified starch, and 50-97 wt % of a starch hydrolysate. The particles are useful for encapsulating active ingredients intended for oral ingestion and may be added to food products. | 2008-08-28 |
20080206326 | Production Process For Nsaid-Containing Lozenges, Their Compositions, Their Medicinal Use - A process for producing a pharmaceutical lozenge formulation comprising the steps of: (a) providing a liquid composition comprising a salt of a non-steroidal anti-inflammatory drug (NSAID salt) and a solvent system, (b) providing a molten lozenge-forming composition, (c) mixing the liquid composition with the molten lozenge-forming composition, and, (d) forming the resulting mixture into lozenges each containing a therapeutically effective amount of said NSAID salt/NSAID mixture. The present application discloses the corresponding NSAID-containing lozenge compositions and their use for the manufacture of a medicament for treating sore throat. | 2008-08-28 |
20080206327 | SOLID DOSAGE FORMULATIONS CONTAINING WEIGHT-LOSS DRUGS - An orally disintegrating tablet which can be chewed or disintegrated by contact with saliva and containing weight-loss drugs for weight control in humans, especially in children and adolescents, is disclosed. | 2008-08-28 |
20080206328 | Hypocholesterolemic Compositions Comprising a Statin and an Antiflatulent Agent - The present invention relates to hypocholesterolemic compositions comprising statins plus antiflatulent agents. In particular the compositions of the present invention comprise a statin selected from the group consisting of atorvastatin, cerivastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin and simvastatin, whether in free form or as pharmaceutically acceptable salts and hydrates thereof, plus an antiflatulent agent. selected from the group consisting of simethicone and dimethicone. The combination of statins plus antiflatulent agents is useful in the prevention and management of flatulence caused by statins. | 2008-08-28 |
20080206329 | Modified Release Ciprofloxacin Compositions - Controlled release tablets comprising ciprofloxacin, with hardness and friability of the said tablets ranges between 10 to 70 kiloponds and less than 2% respectively, the compositions releasing at least 80 percent of the total amount of the ciprofloxacin into a pH 1.2 aqueous dissolution medium within about 1 hour. | 2008-08-28 |
20080206330 | Pharmaceutical Composition - Oral pharmaceutical formulations containing ditosylate salts of 4-quinazolineamines are described as well as methods of using the same in the treatment of disorders characterized by aberrant erbB family PTK activity. | 2008-08-28 |
20080206331 | TABLET COMPRISING EFLETIRIZINE AND PSEUDOEPHEDRINE - The present invention concerns a tablet comprising two distinct segments. More particularly the invention relates to combinations of two pharmaceutical substances and methods of treatment of allergic disorders. | 2008-08-28 |
20080206332 | SUSTAINED RELEASE ORAL DOSAGE FORMS OF A PRODRUG OF R-BACLOFEN AND METHODS OF TREATMENT - Sustained release oral dosage forms of R-baclofen and methods of treating diseases comprising orally administering such dosage forms are disclosed. | 2008-08-28 |
20080206333 | Extended Release Pharmaceutical Formulations of S-Adenosylmethionine - Extended release formulations of S-methyladenosylmethionine (SAMe) are provided, as are methods of treating various disorders using extended release SAMe formulations. The extended release formulations may be used to treat a variety of disorders, including liver disorders, psychiatric disorders and joint disorders. Thus, extended release SAMe formulations may be used to treat alcoholic liver disease, fatty liver disease, hepatitis, generalized anxiety disorder, obsessive compulsive disorder, post traumatic stress disorder, panic disorder, and depressive disorders such as depression (e.g. major clinical depression) and dysthymia. | 2008-08-28 |
20080206334 | Pharmaceutical Polymer Composition For Oral Controlled-Release Delivery Of Terbutaline Sulfate - The present invention is directed to a controlled-release pharmaceutical composition providing a sustained delivery of the basic drug Terbutaline sulfate, said composition comprising at least Terbutaline sulfate or a derivative thereof as an active agent, and further comprising an inactive matrix, said matrix comprising a hydrophilic polysaccharide polymer mixture, said mixture comprising chitosan or a derivative thereof, and further comprising xanthan gum or a derivative thereof, wherein the ratio of xanthan gum and chitosan within said mixture is in the range from about 1:10 to about 10:1, and said composition optionally comprising sodium bicarbonate. | 2008-08-28 |
20080206335 | MULTIPARTICULATE CONTROLLED RELEASE SELECTIVE SEROTONIN REUPTAKE INHIBITOR FORMULATIONS - A multiparticulate controlled release selective serotonin reuptake inhibitor (SSRI) formulation for oral administration comprises particles of said SSRI or a pharmaceutically acceptable salt thereof coated with rate-controlling polymer which allows controlled release of said SSRI, over a period of not less than about 12 hours following oral administration. The formulation, which contains for example fluvoxamine or a pharmaceutically acceptable salt thereof, is suitable for once or twice daily administration. The formulation can comprise a blend of two or more populations of particles, pellets or mini-tablets having different in vitro and/or in vivo release characteristics. | 2008-08-28 |
20080206336 | Novel Composition Comprising Rosiglitazone and Another Antidiabetic Agent - An oral dosage form comprising an erodable core, which core comprises Compound A or a pharmaceutically acceptable salt or solvate thereof and another antidiabetic agent, the core having a coating with one or more openings, characterised in that the coating is erodable under predetermined pH conditions; a process for preparing such a dosage form and the use of such a dosage form in medicine. | 2008-08-28 |
20080206337 | METHOD OF MAKING DOSAGE FORMS COMPRISING POLYMERIC COMPOSITIONS - A dosage form comprises: (a) at least one active ingredient; (b) a core having an outer surface; and (c) a shell which resides upon at least a portion of the core outer surface, wherein at least a portion of the shell is semipermeable, such that the liquid medium diffuses through the semipermeable shell or shell portion to the core due to osmosis. The shell also provides for delivery of the active ingredient to a liquid medium outside the shell after contacting of the dosage form with the liquid medium. The dosage form delivers one or more active ingredients in a controlled manner upon contacting of the dosage form with a liquid medium. The dosage form may be employed to provide a burst release of the active ingredient, or to provide release of the active ingredient at an ascending release rate over an extended time period upon contacting of the dosage form with a liquid medium. At least a portion of the shell may be comprised of a polymeric composition containing film former, gelling agents, which can be dissolved in a multisolvent system comprised of water and an organic solvent. | 2008-08-28 |
20080206338 | CONTROLLED RELEASE FORMULATIONS OF AN ALPHA-ADRENERGIC RECEPTOR ANTAGONIST - The present invention relates to controlled release formulations comprising an alpha-adrenergic receptor antagonist. More particularly, the present invention relates to controlled release matrix formulation comprising alfuzosin hydrochloride and a combination of hydrophilic and hydrophobic polymers prepared by direct compression. | 2008-08-28 |
20080206339 | VERY-PURE SUPERPOROUS HYDROGELS HAVING OUTSTANDING SWELLING PROPERTIES - The invention relates to methods for preparing superporous hydrogels (SPH) that are very-pure and have desirable swelling properties necessary for commercial use, such as in food and pharmaceutical applications. Such methods include simultaneous use of low and high glass transition monomers to improve impurity and swelling profiles of the SPH, use of an integration means to prepare a very homogenous superporous hydrogel foam, washing the superporous hydrogel in a washing solution comprising different ratios of solvent to non-solvent (e.g., water/alcohol), use of a chemically-induced expansion/contraction process to enhance the efficiency of the multiple washing process and to fully structuralize the SPH, and employing one or more separation techniques, such as rubbing, filtration, centrifugation, compression and cutting to increase the efficiency of the purification process and to enhance the SPH swelling properties. | 2008-08-28 |
20080206340 | Galactomannans and/or Glucomannans For Increasing the Bioavailability of Active Substances - The invention relates to a method for increasing the bioavailability of nutrients by using polysaccharides such as galactomannans and similar for introducing active substances, e.g. the human growth hormone HGH and others, into the human or animal metabolism. The aim of the invention is to further develop the production of polysaccharides such as galactomannans and glucomannans in such a way that the same are also suitable for introducing active substances such as the human growth hormone into the human or animal metabolism. | 2008-08-28 |
20080206341 | Lipid Nanoparticles as Vehicles for Nucleic Acids, Process for Their Preparation and Use - The invention relates to solid lipid nanoparticles composed of lipid material and containing, as bioactive molecule, a nucleic acid, preferably an antisense oligonucleotide, preferably modified by chemical methods to achieve a greater resistance to endo- and exo-nucleases, and to the process for preparation of the nanoparticles. In the present invention, the efficiency of the delivery system represented by nanoparticles containing synthetic or natural polynucleotides allows the use of such system for transfection. The particles are especially effective in the treatment of diseases of the posterior segment of the eye (such as diabetic retinopathy, macular degeneration, etc.) and in angiogenesis. | 2008-08-28 |
20080206342 | Compositions and Methods For Increasing the Bioavailability of Pulmonarily Administered Insulin - A pharmaceutical composition suitable for pulmonary delivery includes insulin and EDTA. The presence of EDTA is effective to increase the relative pulmonary bioavailability of the insulin compared to the relative pulmonary bioavailability exhibited by a composition having the same components but absent the EDTA. The composition is in dry powder form. A method of treating or ameliorating diabetes or a related condition in a mammal includes administering by inhalation a pharmacologically effective amount of the composition. A method of improving the pulmonary bioavailability of an insulin composition includes adding EDTA to an insulin composition suitable for pulmonary delivery, wherein the composition is in dry powder form. | 2008-08-28 |
20080206343 | Hepatocytes and Chondrocytes from Adherent Placental StemCells; And CD34+ ,CD45- Placental Stem Cell-Enriched Cell Populations - Provided herein are methods and compositions for the production of hepatocytes from placenta stem cells. Further provided herein is the use of such hepatocytes in the treatment of, and intervention in, for example, trauma, inflammation, and degenerative disorders of the liver. Also provided herein are compositions and methods relating to combinations of nanofibrous scaffolds and adherent placental stem cells and methods of using the same in cartilage repair. Finally, provided herein are compositions and methods relating to nonadherent, CD34 | 2008-08-28 |
20080206344 | ENDOCYTOTIC PARTICLES - Endocytosis of an active agent into a cell having surface receptors can be enhanced by using particles that have a radius no less than an endocytotic threshold determined based on a surface density of the receptors, a surface density of the moieties and interaction parameters that include at least one of a receptor-moiety spring constant and a non-specific interaction strength. | 2008-08-28 |
20080206345 | Methods for Control of Soil-Dwelling Pests and/or Soil-Borne Diseases - A method for the control of soil-dwelling pests and/or soil-borne diseases comprising treating a plant propagation material with an effective amount of the pesticidal composition and/or applying an effective amount of a pesticidal composition to a locus where control is desired, provided that the composition comprises, as active ingredient, one or more pesticides (A) having a water solubility of at most 100 μg/litre, at 25° C. at neutral pH, and at least one formulation auxiliary, wherein the size of particles in the composition is in the range 3.60 μm to 0.70 μm at X | 2008-08-28 |
20080206346 | PREPARATION OF POWDER AGGLOMERATES - The invention relates to a method of producing an agglomerate of drug and solid binder. The process involves producing individual agglomerate particles and then converting the convertible amorphous content of same, following agglomeration, by the application of, for example, moisture. Agglomerates capable of conversion as well as the finished agglomerates and oral and nasal dosing systems including same are also contemplated. The process produces agglomerates which are rugged but which will produce an acceptable fine particle fraction during dosing. | 2008-08-28 |
20080206347 | Pharmaceutical Formulations Comprising Active Pharmaceutical Principles Adsorbed on Titanium Dioxide Nanoparticles - The invention provides methods for the adsorption of an active pharmaceutical ingredient on titianium dioxide nanoparticles which can be orally ingested allowing the drug release into the intestine without causing side effects to the upper gastrointestinal region. | 2008-08-28 |
20080206348 | Cilostazol-Containing Pharmaceutical Composition Based On Particles Of Less Than 50 Micrometers - The present invention relates to cilostazol compositions, process for their preparation, and methods for their administration to treat a condition. In the cilostazol compositions, | 2008-08-28 |
20080206349 | Spray Dried Compositions - The invention provides a method comprising the steps of: (i) providing an emulsion of: a) an aqueous solvent, such as water, b) a carrier material dispersible or soluble in (a), said carrier material being solid at ambient temperature, and preferably being a polymer and inorganic salt or a surfactant, c) a volatile second liquid phase (for example, chloroform) which is not miscible with (a), and d) a material which is dispersible or soluble in (c) but not in (a), and, (ii) Drying the emulsion at above ambient temperature (preferably by spray drying) to simultaneously remove (a) and (c) and thereby obtain the material (b) in solid form with (d) dispersed therein. | 2008-08-28 |
20080206350 | PELLETS HAVING A GASTRIC JUICE-RESISTANT ACTIVE COMPOUND MATRIX - A pellet contains a pharmaceutically active substance embedded in a polymer matrix of one or more water-insoluble polymers; wherein said polymer matrix comprises 10 to 90% by weight of an anionic polymer; with the proviso that the pellet a) releases no more than 10% of said active compound in a release test according to USP in artificial gastric juice at pH 1.2 after 120 min, and b) releases at least 50% of the active compound after altogether a further 300 min at pH 6.8 and/or pH 7.5; wherein said pellet has a particle size in the range from 300 to 1100 μm. | 2008-08-28 |
20080206351 | Malodor Reduction of Cosmetic Products - Malodor free skin care compositions are described. The skin care compositions comprise an adsorbable solvent and an insoluble particle in an adsorbable solvent-insoluble particle complex. The complex is suitable to adsorb components with malodor to yield a skin care composition free of offensive odors like those generated from the oxidation of conjugated linoleic acid. | 2008-08-28 |
20080206352 | Extract for Preventing or Treating Thrombotic Diseases - An extract for preventing or treating thrombotic disease, particularly, an extract of leech and/or earthworm with molecular weight of not more than 5800 Dalton, and processes for preparation, pharmaceutical compositions and uses thereof. The extract of the present invention has improved significantly safety without any reducing in pharmaceutical activities or the therapeutical effects as compared to existing products. | 2008-08-28 |
20080206353 | Formulations And Treatments For Trichology - a formulation for trichological treatment of a patient including, in a dosage in the range of 3 g to 8 g: phytosterols in the range of 200 mg to 2500 mg; the quantitative equivalent of | 2008-08-28 |
20080206354 | Composition for Improving Hair Growth Comprising an Non-Polar Solvent-Soluble Extract of Cantharis as an Active Ingredient - Disclosed herein is a hair growth-stimulating composition containing a non-polar solvent-soluble extract fraction of Cantharis as an active ingredient. The composition shows an excellent hair growth activity with minimal skin irritation compared to conventional ones. It can be used for hair growth in various fields, including medical and non-medical supplies and cosmetics. | 2008-08-28 |
20080206355 | Composition comprising a particulate zinc material, a pyrithione or a polyvalent metal salt of a pyrithione and a synthetic cationic polymer - The present invention relates to a composition comprising a composition comprising an effective amount of a particulate zinc material; an effective amount of a surfactant including a surfactant with an anionic functional group; an effective amount of a pyrithione or a polyvalent metal salt of a pyrithione; from about 0.025% to about 5% by weight of a water soluble or dispersible, cationic, non-crosslinked, conditioning homopolymer having a cationic charge density of from about 2 meq/gm to about 10 meq/gm; and from about 20% to about 95% of an aqueous carrier, by weight of said composition | 2008-08-28 |
20080206356 | Pharmaceutical Compositions for the Treatment of Neurodegenerative Disorders - Pharmaceutical compositions comprising an effective amount of a tungsten (VI) compound, preferably of a tungstate salt, and more preferably of sodium tungstate (Na | 2008-08-28 |
20080206357 | VIF as a traget for HIV inhibition - The present invention relates, e.g., to a method for inhibiting infectivity of a lentivirus (e.g., a lentivirus which expresses a Viral infectivity factor (Vif) protein), such as, e.g., SIV, SHIV and/or HIV, comprising contacting a cell which is producing the virus with an antiviral-effective amount of a membrane-permeable Zinc (Zn) chelator, wherein the antiviral-effective amount of the Zn chelator does not substantially inhibit proteins in the cell which contain Zn-binding motifs other than lentivirus Vif. Kits and pharmaceutical compositions are also disclosed, as is a method for identifying inhibitors of lentiviruses that target a specific zinc-binding motif of the lentivirus Vif protein. | 2008-08-28 |
20080206358 | Pharmaceutically Active Compounds, their Manufacture, Compositions Containing them, and their Use - A substance for use as a medicament, comprises a solid mixed metal compound of formula (I): M | 2008-08-28 |
20080206359 | Day and Night Composition and method for treating Pseudofolliculitis Barbae - An effective formulation for the treatment and prevention of pseudofolliculitis barbae, commonly called razor bumps, and the skin irritation associated with the condition. The treat formulation can be used as the last step in a multi-step shaving system consisting of a shaving gel, aftershave balm and the aforementioned treat. The treat can also be used as a standalone product and is formulated to treat and prevent shaving symptoms day and night. | 2008-08-28 |
20080206360 | Folate based migraine treatment - Formulations for the prevention and treatment of headaches, particularly migraine headaches, comprise folate in combination with one or more of riboflavin, feverfew, or an extract of feverfew, magnesium in the form of acid salts, magnesium oxide, complexes or chelates and/or other nutritional supplements such as vitamin B6, B12, betaine, and plant derived phytochemicals or synthesized versions thereof. | 2008-08-28 |
20080206361 | Insecticidal Compositions Suitable For Use in Preparation of Insecticidal Liquid Fertilizers - Insecticidal compositions suitable for use in preparation of insecticidal liquid fertilizers comprising a pyrethroid, a hydrated aluminum-magnesium silicate, and at least one dispersant selected from the group consisting of a sucrose ester, a lignosulfonate, an alkylpolyglycoside, a naphthalenesulfonic acid formaldehyde condensate and a phosphate ester are disclosed. | 2008-08-28 |
20080206362 | DEVICE AND METHOD FOR INCREASING BLOOD FLOW AND INSULIN-LIKE GROWTH FACTOR - In order to provide a device and a method for increasing blood flow and an insulin-like growth factor with use of a large amount of carbonic gas nano bubbles, the device of the present invention includes: a bathtub | 2008-08-28 |
20080206363 | Skin stabilizer preparation - A method for managing the tolerability of a patient to treatment with a drug that may cause dermatological side effects is provided. An effective amount of a composition which comprises a corticosteroid and sulfur is administered to the skin of such patient. | 2008-08-28 |
20080206364 | Topical nitric oxide as a treatment of autoimmune diseases - The present invention relates to compositions and methods for treatment of a patient affected with an autoimmune disorder, and in an embodiment, a skin-related autoimmune disorder. The treatment involves the application of gaseous nitric oxide to an affected patient, and in an embodiment, to the skin of an affected patient. | 2008-08-28 |
20080206365 | Diterpene compounds having an atisane framework, compositions thereof, and methods of production - Provided are a certain compounds and compositions useful for inhibiting or activating the production of various types of cytokines. Also provided are certain compounds and compositions for preventing or treating various diseases attributable to abnormal cytokine production or compromised immunity. | 2008-08-28 |
20080206366 | COSMETIC COMPOSITION COMPRISING EXTRACT FROM MALLOTUS JAPONICUS FOR IMPROVING SKIN WRINKLE - The present invention relates to compositions for inhibiting elastase activity, enhancing collagen biosynthesis and improving skin wrinkle, comprising | 2008-08-28 |
20080206367 | Morinda Citrifolia-based Formulations and Methods for Weight Management - The present invention relates to formulations and methods for weight management utilizing processed | 2008-08-28 |
20080206368 | Administration of Morinda Citrifolia L. Based Formulations to Increase Birth Rates - The present invention relates to methods and formulations directed to increasing mammalian birth rates comprising the administration of processed | 2008-08-28 |
20080206369 | Nutritional supplement preparation with piperine - A nutritional supplement preparation is provided that includes minerals and trace elements such as vitamin D, calcium, magnesium, selenium, copper, zinc and chromium, as well as at least one catalyst and/or active ingredient, preferably in powder form, which increases and/or improves and/or accelerates the absorption of the minerals and/or trace elements. | 2008-08-28 |
20080206370 | Method For Treating Fungoid Growth of Rhizoctonia, Rythium and Phytophthora - The invention relates to a method for preventing or treating fungoid growth of the specie | 2008-08-28 |
20080206371 | NOVEL BURN TREATMENT COMPOSITION - The invention is directed to a novel topical burn treatment compositions comprising a silicone containing compound, a Vitamin E compound and a local anesthetic. and their use in treating topical burns. | 2008-08-28 |
20080206372 | HERBAL PRODUCT TO BE ADMINISTERED TO DIABETIC PEOPLE AND PROCESS TO OBTAIN IT - Herbal product, for its administration to diabetic people and process to obtain it. The product is made up of the mixture of two plants, one of them belonging to the Myrtaceae family, preferably of the | 2008-08-28 |
20080206373 | Personal Care Composition Comprising Botanical Extract - Personal care composition comprising at least one extract selected from the group consisting of extracts of | 2008-08-28 |
20080206374 | Composition of Radix Codonopsis and Radix Astragali, a Method for Preparation Thereof and its Application - The invention relates to a composition of Radix Codonopsis and Radix Astragali of which the main component is prepared according to a certain weight ratio of Radix Codonopsis and Radix Astragali. The invention also provides a method of preparing the pharmaceutical composition and its applications in the preparation of an immunoregulator and mediciments for the treatment of ischemic heart diseases and acute lung injury. | 2008-08-28 |
20080206375 | Composition of Radix Codonopsis and Radix Astragali, a Method for Preparation Thereof and its Application - The invention relates to a composition of Radix Codonopsis and Radix Astragali of which the main component is prepared according to a certain weight ratio of Radix Codonopsis and Radix Astragali. The invention also provides a method of preparing the pharmaceutical composition and its applications in the preparation of an immunoregulator and medicaments for the treatment of ischemic heart diseases and acute lung injury. | 2008-08-28 |
20080206376 | METHODS AND COMPOSITIONS FOR INHIBITING ANGIOTENSIN CONVERTING AND CHYMASE ENZYMES - The present invention relates to medicinal products, as well as to health and wellness food products, and particularly to a medicinal product or a health and wellness food product for inhibiting Angiotensin Converting Enzyme and Chymase enzyme pathways. | 2008-08-28 |
20080206377 | Topical Compositions and Methods For Alleviating or Inhibiting Symptoms Associated With Carpal Tunnel Syndrome, Acid Reflux, Psoriasis, Cartilage Nodules, Fibromyalgia, and Diabetes - The present invention provides a method of alleviating or inhibiting one or more symptoms associated with carpal tunnel syndrome, acid reflux, psoriasis, cartilage nodules, fibromyalgia, diabetes, or hypoglycemia in a mammal. The method comprises the step of contacting the mammal's skin with a composition that includes a fruit-vegetable extract. The fruit-vegetable extract is present in an amount effective to alleviate or inhibit one or more symptoms associated with carpal tunnel syndrome, acid reflux, psoriasis, cartilage nodules, fibromyalgia, diabetes, or hypoglycemia in the mammal. | 2008-08-28 |
20080206378 | Anthelmintic Composition - A topical formulation comprising as active ingredients, at least one effective agent derived from | 2008-08-28 |
20080206379 | Production and Use of an Antioxidant Extract from Crypthecodinium Sp. - The invention relates to an antioxidant extract from | 2008-08-28 |
20080206380 | Preventing Agent Against Drug-Resistant Bacterial Infection - The present invention is to provide an agent for preventing and treating drug-resistant bacterial infection for livestock/fowls or fish and shellfish, using particular microbial agents as active components, without using synthetic antibacterial substances or antibiotics, and a method for preventing and treating its infection. By using lactic acid bacteria, their dead bacteria or treated substances thereof, or | 2008-08-28 |
20080206381 | METHODS AND SYSTEMS FOR MANUFACTURING YARNS FOR SYNTHETIC TURF - Systems and methods for manufacturing synthetic yarns for synthetic turf. The systems and methods include rollers for advancing a plastic sheet forward through a manufacturing process. The plastic sheet is cooled and heated on opposing sides by alternating temperature rollers to pre-form the plastic sheet such that subsequent synthetic yarns made from the sheet will have a curled shape. The plastic sheet is then cut longitudinally by a plurality of slitting blades along the length of the sheet to form a plurality of single strand synthetic yarns. A drawing device then draws and stretches the single strand synthetic yarns to a desired width and thickness, wherein the drawing device includes a drawing oven for heating the yarns, and a plurality of drawing rollers for pulling and stretching the heated yarns. The final product drawn yarns comprise sealed, smooth yarns with desirable rounded edges and a curled tip. | 2008-08-28 |
20080206382 | MOLDING MACHINE, CLAMPING SYSTEM, BURR DETECTION METHOD, AND ABNORMALITY DETECTION METHOD - A molding machine able to detect a burr or other abnormality by detecting the position of tie bars. A control device detects an occurrence of burrs according to whether or not displacement amounts of pistons associated with the tie bars, using position sensors which detect the position of the pistons. The position sensors detect position from the start of injection to the completion of the injection to determine whether detected values are within a permissible range. | 2008-08-28 |
20080206383 | Solid Imaging System with Removal of Excess Uncured Build Material - Solid imaging apparatus and methods for use are disclosed that reduce the amount of uncured solid imaging build material remaining on a completed build object following the completion of the solid imaging build process. The amount of uncured build material is reduced through the use of either an uncoating web that removes excess build material from the build object during the course of the building process or an ink jet source of build material that uses only as much build material as is necessary for the fabrication of the build part. Also disclosed is an imager assembly for use with such a solid imaging apparatus that incorporates two or more individual imagers in an array and accounts for variations in the intensity and alignment of adjacent imagers. The apparatus can be modified for semi-continuous operation and for integrating into a manufacturing operation, if desired. | 2008-08-28 |
20080206384 | PROCESS FOR THE PRESS CONTROL OF A POWDER METAL PRESS IN THE PRODUCTION OF MOLDINGS - The invention concerns a press for the production of pressed moldings of powdery or granulate materials, as well as a process for controlling the press where a correction of the ram stroke of the press is initiated depending on the association of actual dimensions of the molding with certain tolerance ranges to which different valences have been assigned, and where, depending on the valence in question, no correction, an immediate correction, or a delayed correction of the ram stroke is effected. | 2008-08-28 |
20080206385 | High Force Indentation Apparatus With High Accuracy - The invention relates to an indentation apparatus ( | 2008-08-28 |
20080206386 | Device for Eliminating Oversize Pellets from Balling Disks - Device for eliminating oversize pellets from balling disks, comprised of a plow-like tool ( | 2008-08-28 |
20080206387 | MOLD-CONVEYING DEVICE FOR PLASTIC BLOW-MOLDING MACHINE - A mold-conveying device for an plastic blow-molding machines includes a machine base and an auxiliary mold base. The machine base is located under a main mold base for positioning the lower mol d of a shaping mold thereon, provided with plural correcting rods fitted in correcting rod holes in the bottom base of the auxiliary mold base. Further, a power member is provided under the auxiliary mold base for raising or lowering the auxiliary mold base, and the auxiliary mold base is provided with a transmitting device having a transmitting member to match with a rack provided in the machine base for shifting the auxiliary mold base rightward and leftward in accordance with the blow-molding movements of the plastic blow-molding machines for carrying out mold conveying. | 2008-08-28 |
20080206388 | Doughnut making machine - Doughnut making machine with a metal trough, a heating element, a doughnut pushing chain assembly, a chain drive motor, a doughnut batter hopper, a motorized batter dispensing mechanism, a plurality of chain idler pulleys, a chain drive motor and attached pulley, and doughnut flipping fingers. The is chain is wrapped into a belt and is driven by the chain drive pulley that is in turn driven by the chain drive motor. The chain is wrapped around the idler pulleys in a secure fashion. The dispensing mechanism activates when the belt switch activators contact a dough dispensing switch located on the chain. The batter is dropped into the oil that resides in the trough. The heated oil causes the doughnut mixture to fry. The resulting doughnut shape is propelled forward by chain push fingers. The flipping fingers offer resistance to the doughnut causing it to flip over. | 2008-08-28 |
20080206389 | Cooked rice mold apparatus - Provided is a cooked rice mold apparatus that can easily adjust the supply amount of sushi rice. The roller spacing of a top rolling roller pair | 2008-08-28 |
20080206390 | BLOW MOLD - Blow mold for producing plastic containers, having a base body in the interior of which a body of the container to be produced can be accommodated and the inside wall of which completely surrounds the container that is to be produced, such that the blow mold has a ring for supporting a neck of the container with respect to the blow mold, along with a spacer device protruding inward with respect to the circumferential edge of the ring, for preventing the body of the container from coming in contact with the inside wall of the blow mold in the event of tilting of the container with respect to the blow mold. | 2008-08-28 |
20080206391 | Injection Molding Nozzle Assembly with Composite Nozzle Tip - A nozzle assembly for an injection molding assembly has a nozzle housing having a melt channel extending therethrough, a nozzle tip, and a retainer that retains the nozzle tip against the nozzle housing. The nozzle tip is formed of a precipitation hardened, high thermal conductivity material and a precipitation hardened, high strength material, which are integrally joined together to form the body. The thermal conductivity of the high thermal conductivity material is greater than the thermal conductivity of the high strength material, and the strength of the high strength material is greater than the strength of the high thermal conductivity material. The high thermal conductivity material and the high strength material can be precipitation hardened together under the same precipitation hardening conditions to achieve increases in the value of at least one strength aspect of the high thermal conductivity material and the value of at least one strength aspect of the high strength material. | 2008-08-28 |
20080206392 | Production Process of Plastic Parts by Reaction Injection Moulding, and Related Head Device - The present invention relates to a process and device RIM involving a mixing chamber ( | 2008-08-28 |
20080206393 | Mold Device for Forming - Disclosed herein is a mold device for forming a product using molten molding material. In the present invention, parting surfaces ( | 2008-08-28 |
20080206394 | Composite Nozzle Tip Method - A composite nozzle tip for an injection molding assembly includes a body, having a bore extending therethrough, adapted for connection to the injection molding assembly. The body is formed of a precipitation hardened, high thermal conductivity material and a precipitation hardened, high strength material, which are integrally joined together to form the body. The thermal conductivity of the high thermal conductivity material is greater than the thermal conductivity of the high strength material, and the strength of the high strength material is greater than the strength of the high thermal conductivity material. The high thermal conductivity material and the high strength material can be precipitation hardened together under the same precipitation hardening conditions to achieve increases in the value of at least one strength aspect of the high thermal conductivity material and the value of at least one strength aspect of the high strength material, relative to their respective unhardened conditions. | 2008-08-28 |
20080206395 | Composite Injection Molding Component - A composite material component for an injection molding assembly includes a first portion formed of a precipitation hardened, high thermal conductivity material and a second portion formed of a precipitation hardened, high strength material, which are integrally joined together. The thermal conductivity of the high thermal conductivity material is greater than the thermal conductivity of the high strength material, and at least one strength aspect of the high strength material has a value greater than the corresponding value of the same strength aspect of the high thermal conductivity material. The high thermal conductivity material and the high strength material can be precipitation hardened together under the same precipitation hardening conditions to achieve increases in the value of at least one strength aspect of the high thermal conductivity material and the value of at least one strength aspect of the high strength material, relative to their respective unhardened conditions. | 2008-08-28 |
20080206396 | Hot Runner System with Composite Nozzle Tip - A hot runner assembly for an injection molding assembly includes an injection unit adapted to contain a flowable material, a manifold having a first segment of a melt channel formed therein, a nozzle assembly connected to the manifold including a nozzle housing and a nozzle tip, a retainer that retains the nozzle tip against the nozzle housing, and a mold cavity. The nozzle tip is formed of a precipitation hardened, high thermal conductivity material and a precipitation hardened, high strength material, which are integrally joined together to form the body. The thermal conductivity of the high thermal conductivity material is greater than the thermal conductivity of the high strength material, and the strength of the high strength material is greater than the strength of the high thermal conductivity material. The high thermal conductivity material and the high strength material can be precipitation hardened together under the same precipitation hardening conditions. | 2008-08-28 |
20080206397 | Packaged Artificial Soft Baits - A method for packaging is described for enhancing the attractiveness of an artificial hydrophilic polymeric soft fish bait to fish, comprising: immersing or suspending said soft bait in a package with an aqueous suspension of biological fluids from an animal, the water-soluble fraction of biological fluids from an animal, or an artificial simulated fluid thereof, so that the soft bait absorbs said fluid and an animal odor/flavor components contained therein. | 2008-08-28 |
20080206398 | Methods for Enhancing the Quality of Life of a Senior Animal - Methods for enhancing the quality of life of a senior or super senior animals by feeding the animal a composition comprising at least one omega-3 polyunsaturated fatty acid and various combinations of amino acids, minerals, and antioxidants in amounts effective to enhance alertness, improve vitality, protect cartilage, maintain muscle mass, enhance digestibility, and improve skin and pelage quality. | 2008-08-28 |
20080206399 | Method and Use of a Laccase Enzyme in a Baked Product - The present invention relates to a method of preparing a baked product from dried masa flour, wherein an enzyme capable of polymerizing polyphenolics is added to the dough, as well as to a use of such an enzyme in a baked product made from non-leavened dough comprising dried masa flour. | 2008-08-28 |
20080206400 | Bread-Improving Agent and Bread Products Using the Same - It is intended to provide a bread-improving agent which shows a highly excellent preservative effect of imparting antifungal properties while sustaining effects of improving the physical properties and taste of bread products. A fermented soybean protein material having been treated with a microorganism belonging to the genus | 2008-08-28 |
20080206401 | INCREASED DENSITY PET FOOD PRODUCT AND METHOD OF PRODUCTION - An increased density dry pet food product is provided having a bulk density of 25 to pounds per cubic food, residual α-amylase activity in the range of 0.1 to 57 NU per gram of the pet food product, and having a maintained or increased softness. A method of producing the dry pet food product is also provided. | 2008-08-28 |
20080206402 | Food Products Containing Legume Products and Processes for Producing the Food Products - Food products containing legume products, as well as processes for producing the food products are disclosed. | 2008-08-28 |
20080206403 | Probiotic Enriched and Low-Organic Acid Food Products - This invention relates to a fruit-based food product such as beverages or fruit purees, comprising a concentration of live and stable probiotics, which is preferably greater than 10 | 2008-08-28 |
20080206404 | Composite Frozen Confections - A reformed biscuit product suitable for forming composite frozen compositions includes a solid mixture of a particulate cooked biscuit material and a cocoa butter equivalent of a confectionery fat is described. A process for manufacturing the product includes coating the particles with the fat, compacting the mixture of particulate biscuit and fat in an agglomerate of the shape of a receptacle or coating and maintaining the shape of the compacted mixture by solidification of the fat. Also described is a process for manufacturing a composite frozen confection comprising a reformed biscuit product formed into a cone containing an ice confection such as ice cream. | 2008-08-28 |
20080206405 | Pet Treat Containing Organic Nutrients - The present disclosure relates to a pet treat comprising a resin and nutritional additive wherein the nutritional additive includes an oil including one or more of a salmon oil, hemp oil and evening primrose oil. The pet treat is at least 70% organic and may be formed by melt processing techniques, such as extrusion or injection molding. The pet treat may also include a nutritional additive which may be present in particulate form wherein the particles have a size of less than or equal to about 250 microns. | 2008-08-28 |
20080206406 | Modified Proteins With Altered Aggregation Properties - The invention relates a method for preparing modified proteins having an increased capacity to bind divalent cations. For example the concentration of calcium at which Ca | 2008-08-28 |
20080206407 | Sachets Comprising Plant Sterol - The invention relates to a porous sachet comprising plant sterol, emulsifier and a particulate material such as tea leaves. | 2008-08-28 |
20080206408 | INFUSION/STRAINER DEVICE AND METHOD FOR MANUFACTURING THE STRAINER - A straining/stirring device and a method for manufacturing a straining device are provided. The straining device includes a handle, a frame, which is positioned at an end of the handle, and a compartment containing a medium to be strained. The compartment includes a top porous surface and a bottom porous surface, and is affixed to the frame. Further, the compartment is configured so as to strain the medium through at least one of the top porous surface and the bottom porous surface. The medium to be strained may include a beverage, medicine, or soup ingredient. Accordingly, the straining device provides a convenient apparatus for preparing a beverage, a food, or a medicine, and for a variety of utensil applications such as stirring or collecting and adding an additive. | 2008-08-28 |
20080206409 | Filled confectionary product and process - A filled candy cane formed by injecting a soft candy into a hardening, elongate candy. A method and means for same. | 2008-08-28 |
20080206410 | Liquid Egg Material - Described are homogenized liquid egg products, which may be prepared by subjecting liquid whole egg material to sufficient ultrasonic energy to prepare a homogenized liquid egg product. Also disclosed are methods for treating liquid egg material with ultrasonic energy to prepare homogenized liquid egg products. | 2008-08-28 |
20080206411 | Foodstuff - The present invention provides a foodstuff comprising:
| 2008-08-28 |
20080206412 | Supplementary Food Compositions - A supplementary food composition comprising at least one organic mineral salt that contributes to alkaline power in a quantity ranging from 20 to 200 mEq and is capable of neutralizing an acidic charge of 20 to 200 mEq of H | 2008-08-28 |
20080206413 | Low Trans Puff Pastry Composition, Method of Use and Puff Pastry Products - Disclosed are improvements in puff pastry preparation, which reduce, and preferably eliminate, trans unsaturated fatty acids by the use of a new puff pastry fat comprised principally of palm olein, which is preferably interesterified. The puffed pastry fats exhibit low levels of trans fatty acids. The puff pastry fats and products are highly functional without resort to high solids contents, hydrogenation or butter or other animal fats. | 2008-08-28 |
20080206414 | PRESERVATIVE METHOD - A method for producing a microbiologically stable and safe food composition is described The method includes the step of mixing a food composition comprising an anionic polymer with a saturated preservative having an overall positive charge, whereby the saturated preservative is added in the last mixing step, in order to produce a food composition free of spoilage and pathogens. | 2008-08-28 |
20080206415 | PROTEIN BEVERAGE AND METHOD OF MAKING THE SAME - A protein beverage composition and a method of making it relate to a beverage including a protein essentially free of caseinate and derived from an aqueous protein isolate collected from membrane-filtration isolation of the protein and without substantial drying the protein beverage composition exhibits a pH ranging from about 2.0 to about 4.6. Substantial solubility of the protein is maintained in the beverage composition, and the protein beverage is essentially free of active microbes known to be harmful to human health, both at the time of packaging of the protein beverage and for a time period of at least one year after packaging. | 2008-08-28 |